These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27973456)

  • 21. Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain.
    Nagae M; Nishi N; Murata T; Usui T; Nakamura T; Wakatsuki S; Kato R
    Glycobiology; 2009 Feb; 19(2):112-7. PubMed ID: 18977853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function studies of galectin-14, an important effector molecule in embryology.
    Si Y; Li Y; Yang T; Li X; Ayala GJ; Mayo KH; Tai G; Su J; Zhou Y
    FEBS J; 2021 Feb; 288(3):1041-1055. PubMed ID: 32525264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity.
    Sato M; Nishi N; Shoji H; Seki M; Hashidate T; Hirabayashi J; Kasai Ki K; Hata Y; Suzuki S; Hirashima M; Nakamura T
    Glycobiology; 2002 Mar; 12(3):191-7. PubMed ID: 11971863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-domain of human adhesion/growth-regulatory galectin-9: preference for distinct conformers and non-sialylated N-glycans and detection of ligand-induced structural changes in crystal and solution.
    Solís D; Maté MJ; Lohr M; Ribeiro JP; López-Merino L; André S; Buzamet E; Cañada FJ; Kaltner H; Lensch M; Ruiz FM; Haroske G; Wollina U; Kloor M; Kopitz J; Sáiz JL; Menéndez M; Jiménez-Barbero J; Romero A; Gabius HJ
    Int J Biochem Cell Biol; 2010 Jun; 42(6):1019-29. PubMed ID: 20227520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.
    Li Y; Feng J; Geng S; Geng S; Wei H; Chen G; Li X; Wang L; Wang R; Peng H; Han G; Shen B; Li Y
    Mol Immunol; 2011 Jan; 48(4):670-7. PubMed ID: 21146220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key amino acid residues determining ligand binding specificity, homodimerization and cellular distribution of human galectin-10.
    Su J; Song C; Si Y; Cui L; Yang T; Li Y; Wang H; Tai G; Zhou Y
    Glycobiology; 2019 Jan; 29(1):85-93. PubMed ID: 30239701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR assignments of the C-terminal domain of human galectin-8.
    Liu CH; Chien CT; Lin CH; Hsu ST
    Biomol NMR Assign; 2015 Oct; 9(2):427-30. PubMed ID: 26126590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallization of a human galectin-3 variant with two ordered segments in the shortened N-terminal tail.
    Flores-Ibarra A; Vértesy S; Medrano FJ; Gabius HJ; Romero A
    Sci Rep; 2018 Jun; 8(1):9835. PubMed ID: 29959397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptides derived from human galectin-3 N-terminal tail interact with its carbohydrate recognition domain in a phosphorylation-dependent manner.
    Berbís MÁ; André S; Cañada FJ; Pipkorn R; Ippel H; Mayo KH; Kübler D; Gabius HJ; Jiménez-Barbero J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):126-31. PubMed ID: 24269589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The water network in galectin-3 ligand binding site guides inhibitor design.
    Su J; Zhang T; Wang P; Liu F; Tai G; Zhou Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):192-8. PubMed ID: 25662390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-ray structures of human galectin-9 C-terminal domain in complexes with a biantennary oligosaccharide and sialyllactose.
    Yoshida H; Teraoka M; Nishi N; Nakakita S; Nakamura T; Hirashima M; Kamitori S
    J Biol Chem; 2010 Nov; 285(47):36969-76. PubMed ID: 20861009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of the glycan specificities of cell-bound human tandem-repeat-type galectin-4, -8 and -9.
    Vokhmyanina OA; Rapoport EM; André S; Severov VV; Ryzhov I; Pazynina GV; Korchagina E; Gabius HJ; Bovin NV
    Glycobiology; 2012 Sep; 22(9):1207-17. PubMed ID: 22547138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.
    Labrie M; Vladoiu M; Leclerc BG; Grosset AA; Gaboury L; Stagg J; St-Pierre Y
    PLoS One; 2015; 10(7):e0131307. PubMed ID: 26168167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural Characterization of Rat Galectin-5, an N-Tailed Monomeric Proto-Type-like Galectin.
    Ruiz FM; Medrano FJ; Ludwig AK; Kaltner H; Shilova NV; Bovin NV; Gabius HJ; Romero A
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterisation of human galectin-4 N-terminal carbohydrate recognition domain in complex with glycerol, lactose, 3'-sulfo-lactose, and 2'-fucosyllactose.
    Bum-Erdene K; Leffler H; Nilsson UJ; Blanchard H
    Sci Rep; 2016 Feb; 6():20289. PubMed ID: 26828567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamic binding studies of bivalent oligosaccharides to galectin-1, galectin-3, and the carbohydrate recognition domain of galectin-3.
    Ahmad N; Gabius HJ; Sabesan S; Oscarson S; Brewer CF
    Glycobiology; 2004 Sep; 14(9):817-25. PubMed ID: 15148296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary X-ray crystallographic analysis of an engineered variant of human chimera-type galectin-3 with a shortened N-terminal domain.
    Flores-Ibarra A; Ruiz FM; Vértesy S; André S; Gabius HJ; Romero A
    Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):184-8. PubMed ID: 25664793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution.
    Seetharaman J; Kanigsberg A; Slaaby R; Leffler H; Barondes SH; Rini JM
    J Biol Chem; 1998 May; 273(21):13047-52. PubMed ID: 9582341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-10: a new structural type of prototype galectin dimer and effects on saccharide ligand binding.
    Su J; Gao J; Si Y; Cui L; Song C; Wang Y; Wu R; Tai G; Zhou Y
    Glycobiology; 2018 Mar; 28(3):159-168. PubMed ID: 29293962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resetting the ligand binding site of placental protein 13/galectin-13 recovers its ability to bind lactose.
    Su J; Cui L; Si Y; Song C; Li Y; Yang T; Wang H; Mayo KH; Tai G; Zhou Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.